BioSenic S.A.
BIOS.BR · BRU
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €3 | €0 |
| % Growth | – | -100% | 1,413.5% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €0 | -€0 | €3 | -€0 |
| % Margin | – | – | 100% | -49.4% |
| R&D Expenses | €0 | €1 | €2 | €1 |
| G&A Expenses | €0 | €0 | €2 | €2 |
| SG&A Expenses | €0 | €4 | €2 | €2 |
| Sales & Mktg Exp. | €0 | €0 | -€0 | €0 |
| Other Operating Expenses | €0 | €0 | €0 | -€0 |
| Operating Expenses | €0 | €5 | €3 | €3 |
| Operating Income | -€0 | -€5 | -€0 | -€3 |
| % Margin | – | – | -17.3% | -1,862.9% |
| Other Income/Exp. Net | -€0 | -€2 | €1 | -€5 |
| Pre-Tax Income | -€1 | -€7 | €0 | -€8 |
| Tax Expense | €0 | €0 | -€0 | -€0 |
| Net Income | -€1 | -€5 | €0 | -€8 |
| % Margin | – | – | 18.4% | -4,457.9% |
| EPS | -0.001 | -0.016 | 0.25 | -0.053 |
| % Growth | 93.2% | -106.5% | 571.7% | – |
| EPS Diluted | -0.001 | -0.016 | 0.25 | -0.053 |
| Weighted Avg Shares Out | 653 | 324 | 2 | 150 |
| Weighted Avg Shares Out Dil | 653 | 324 | 2 | 150 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €1 | €1 | €10 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€1 | -€6 | -€0 | -€3 |
| % Margin | – | – | -13.4% | -1,683.1% |